Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Trends and Outcomes of Transcatheter Aortic Valve Implantation (TAVI) in Korea: the Results of the First Cohort of Korean TAVI Registry

  • Yu, Cheol Woong (Department of Cardiology, Korea University Anam Hospital, Department of Internal Medicine, Korea University College of Medicine) ;
  • Kim, Won-Jang (Department of Cardiology, CHA Bundang Medical Center, Department of Internal Medicine, CHA University School of Medicine) ;
  • Ahn, Jung-Min (Department of Cardiology, Asan Medical Center, Department of Internal Medicine, University of Ulsan College of Medicine) ;
  • Kook, Hyungdon (Department of Cardiology, Korea University Anam Hospital, Department of Internal Medicine, Korea University College of Medicine) ;
  • Kang, Se Hun (Department of Cardiology, CHA Bundang Medical Center, Department of Internal Medicine, CHA University School of Medicine) ;
  • Han, Jung-Kyu (Department of Cardiology, Seoul National University Hospital, Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Ko, Young-Guk (Department of Cardiology, Severance Hospital, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Choi, Seung-Hyuk (Department of Cardiology, Samsung Medical Center, Department of Internal Medicine, Sungkyunkwan University School of Medicine) ;
  • Koo, Bon-Kwon (Department of Cardiology, Seoul National University Hospital, Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Chang, Kiyuk (Department of Cardiology, Seoul St. Mary's Hospital, Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Kim, Hyo-Soo (Department of Cardiology, Seoul National University Hospital, Department of Internal Medicine, Seoul National University College of Medicine)
  • Received : 2018.04.09
  • Accepted : 2018.04.14
  • Published : 2018.05.31
⟨ Previous Next ⟩

Abstract

Background and Objectives: There has been no nation-wide data on the outcomes of transcatheter aortic valve implantation (TAVI) after commercialization of TAVI in Korea. We report clinical features and outcomes of the first cohort of TAVI performed from Jun 2015 to Jun 2017 in Korea. Methods: The first cohort of Korean-TAVI (K-TAVI) registry includes 576 consecutive patients with severe symptomatic aortic stenosis who underwent TAVI from 17 Korean hospitals for 2 years. Results: Most of TAVI procedures were performed for septuagenarians and octogenarians (90.8%) through transfemoral approach (98.3%). The rate of device success was 92.5% and permanent pacemaker was implanted in 5.6%. In successive years, incidences of paravalvular leakage (PVL) and major bleeding declined. Society of Thoracic Surgeons (STS) score was 5.2 (3.0 to 9.0) and 34.7% of patients had high surgical risk (STS ${\geq}8$). One-year all-cause death occurred in 8.9% and was significantly lower in low to intermediate risk one than in high risk (5.4% vs. 15.5%, p<0.001). The independent predictors of 1-year mortality were age (hazard ratio [HR], 1.087; 95% confidence interval [CI], 1.036-1.141; p=0.001), moderate or severe PVL (HR, 4.631; 95% CI, 1.624-13.203; p=0.004) and end-stage renal disease (HR, 5.785; 95% CI, 2.717-12.316; p<0.001). Conclusions: K-TAVI registry showed favorable 1-year outcomes with decreasing complication rate over time in real-world Korean patients. Two-thirds of patients were low to intermediate surgical risk and showed a significantly lower mortality than the high-risk patients, suggesting the promising future on the expanded indications of TAVI.

Keywords

References

  1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607. https://doi.org/10.1056/NEJMoa1008232
  2. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98. https://doi.org/10.1056/NEJMoa1103510
  3. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609-20. https://doi.org/10.1056/NEJMoa1514616
  4. Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321-31. https://doi.org/10.1056/NEJMoa1700456
  5. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. https://doi.org/10.1016/j.jacc.2007.04.047
  6. Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 2012;33:2403-18. https://doi.org/10.1093/eurheartj/ehs255
  7. Sawa Y, Saito S, Kobayashi J, et al. First clinical trial of a self-expandable transcatheter heart valve in Japan in patients with symptomatic severe aortic stenosis. Circ J 2014;78:1083-90. https://doi.org/10.1253/circj.CJ-14-0162
  8. Mack MJ, Brennan JM, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA 2013;310:2069-77. https://doi.org/10.1001/jama.2013.282043
  9. Ludman PF, Moat N, de Belder MA, et al. Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. Circulation 2015;131:1181-90. https://doi.org/10.1161/CIRCULATIONAHA.114.013947
  10. Takimoto S, Saito N, Minakata K, et al. Favorable clinical outcomes of transcatheter aortic valve implantation in Japanese patients- first report from the Post-Approval K-TAVI Registry. Circ J 2016;81:103-9.
  11. Sinning JM, Ghanem A, Steinhauser H, et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010;3:1141-9. https://doi.org/10.1016/j.jcin.2010.09.009
  12. Van Mieghem NM, van der Boon RM, Nuis RJ, et al. Cause of death after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2014;83:E277-82. https://doi.org/10.1002/ccd.24597
  13. Barbash IM, Finkelstein A, Barsheshet A, et al. Outcomes of patients at estimated low, intermediate, and high risk undergoing transcatheter aortic valve implantation for aortic stenosis. Am J Cardiol 2015;116:1916-22. https://doi.org/10.1016/j.amjcard.2015.09.030

Cited by

  1. Simultaneous Estimation of Gender Male and Atrial Fibrillation as Risk Factors for Adverse Outcomes Following Transcatheter Aortic Valve Implantation vol.9, pp.12, 2018, https://doi.org/10.3390/jcm9123963
  2. Post-operative Atrial Fibrillation Impacts on Outcomes in Transcatheter and Surgical Aortic Valve Replacement vol.8, pp.None, 2021, https://doi.org/10.3389/fcvm.2021.789548